FDA approves Novocure’s new flexible HFE arrays for glioblastoma treatment
Novocure has received FDA approval for its innovative Head Flexible Electrode (HFE) transducer arrays, designed to enhance the comfort of glioblastoma multiforme (GBM) patients using Optune Gio. This wearable device, a cornerstone of Tumor Treating Fields (TTFields) therapy, delivers alternating electric fields to disrupt the rapid division of cancer cells. The approval marks a step […]